$IDAI
T Stamp Inc

2023 Q1 Form 10-K Financial Statement

#000141057823000453 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $458.6K $507.3K $5.385M
YoY Change -83.74% -75.8%
Cost Of Revenue $217.0K $214.0K $1.785M
YoY Change -68.74% -28.11% 55.09%
Gross Profit $241.7K $293.3K $3.600M
YoY Change -88.64% -83.69% 42.47%
Gross Profit Margin 52.69% 57.81% 66.85%
Selling, General & Admin $1.970M $3.429M $12.44M
YoY Change -36.87% 55.05% 49.67%
% of Gross Profit 815.11% 1169.27% 345.68%
Research & Development $632.4K $708.2K $2.474M
YoY Change 28.09% -49.51% -2.18%
% of Gross Profit 261.67% 241.47% 68.73%
Depreciation & Amortization $219.2K $212.8K $760.5K
YoY Change 42.39% 40.87% 32.55%
% of Gross Profit 90.69% 72.55% 21.13%
Operating Expenses $3.038M $4.350M $17.46M
YoY Change -31.91% 15.53% 38.95%
Operating Profit -$2.580M -$4.057M -$12.08M
YoY Change 57.19% 106.26% 35.86%
Interest Expense -$11.57K $25.07K $104.2K
YoY Change -131.59% -187.38% -182.14%
% of Operating Profit
Other Income/Expense, Net $32.30K $18.27K $8.459K
YoY Change -163.41% -164.67% -105.04%
Pretax Income -$2.547M -$4.016M -$12.07M
YoY Change 50.55% 98.45% 33.24%
Income Tax $0.00 $21.08K $21.08K
% Of Pretax Income
Net Earnings -$2.547M -$4.037M -$12.09M
YoY Change 50.55% 99.54% 33.5%
Net Earnings / Revenue -555.44% -795.89% -224.54%
Basic Earnings Per Share -$0.50 -$2.55
Diluted Earnings Per Share -$0.50 -$0.80 -$2.55
COMMON SHARES
Basic Shares Outstanding 4.854M 24.26M 4.733M
Diluted Shares Outstanding 5.045M 4.733M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $773.1K $1.254M $1.254M
YoY Change -86.75% -63.91% -63.91%
Cash & Equivalents $773.1K $1.254M $1.254M
Short-Term Investments
Other Short-Term Assets $297.9K $290.1K $281.7K
YoY Change -71.91% -68.73% -66.96%
Inventory
Prepaid Expenses $236.5K $225.8K
Receivables $533.5K $1.008M $1.008M
Other Receivables $195.1K $321.4K $329.8K
Total Short-Term Assets $1.800M $2.874M $2.874M
YoY Change -77.76% -50.13% -50.13%
LONG-TERM ASSETS
Property, Plant & Equipment $82.11K $300.7K $616.4K
YoY Change -26.42% 169.01% 451.52%
Goodwill $1.249M $1.249M
YoY Change 0.0% 0.0%
Intangibles $238.8K $251.7K
YoY Change 16.7% 24.72%
Long-Term Investments
YoY Change
Other Assets $2.066K $2.066K
YoY Change -98.63% -98.84%
Total Long-Term Assets $3.361M $3.538M $3.538M
YoY Change 13.47% 21.97% 21.97%
TOTAL ASSETS
Total Short-Term Assets $1.800M $2.874M $2.874M
Total Long-Term Assets $3.361M $3.538M $3.538M
Total Assets $5.161M $6.412M $6.412M
YoY Change -53.31% -26.0% -26.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.365M $945.2K $945.2K
YoY Change 108.79% 210.77% 210.76%
Accrued Expenses $1.191M $1.100M $1.278M
YoY Change -9.66% 3.8% 20.58%
Deferred Revenue $2.747M $1.812M
YoY Change 754.45% 259.87%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $118.9K $118.9K
YoY Change
Total Short-Term Liabilities $5.893M $4.448M $4.329M
YoY Change 139.05% 85.32% 80.36%
LONG-TERM LIABILITIES
Long-Term Debt $907.6K $886.5K $886.5K
YoY Change 8.29% 3.53% 3.53%
Other Long-Term Liabilities $319.7K $571.6K $571.6K
YoY Change -4.33% 52.55% 52.55%
Total Long-Term Liabilities $907.6K $886.5K $1.458M
YoY Change 8.29% 3.53% 18.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.893M $4.448M $4.329M
Total Long-Term Liabilities $907.6K $886.5K $1.458M
Total Liabilities $7.120M $5.787M $5.948M
YoY Change 95.75% 59.37% 56.85%
SHAREHOLDERS EQUITY
Retained Earnings -$41.85M -$39.30M
YoY Change 44.81% 44.44%
Common Stock $51.22K $48.54K
YoY Change -77.97% -76.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.120M $463.7K $463.7K
YoY Change
Total Liabilities & Shareholders Equity $5.161M $6.412M $6.412M
YoY Change -53.31% -26.0% -26.0%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.547M -$4.037M -$12.09M
YoY Change 50.55% 99.54% 33.5%
Depreciation, Depletion And Amortization $219.2K $212.8K $760.5K
YoY Change 42.39% 40.87% 32.55%
Cash From Operating Activities -$155.0K -$1.496M -$6.340M
YoY Change -86.4% 3.62% -5.58%
INVESTING ACTIVITIES
Capital Expenditures $191.2K $263.1K $30.84K
YoY Change 1801.08% -292.87% -9.86%
Acquisitions
YoY Change
Other Investing Activities $0.00 $13.36K
YoY Change -114.74%
Cash From Investing Activities -$191.2K -$263.1K -$998.2K
YoY Change -21.87% 92.9% 29.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $983.2K
YoY Change -87.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -103.1K 21.90K 5.101M
YoY Change -102.79% -99.55% -45.44%
NET CHANGE
Cash From Operating Activities -155.0K -1.496M -6.340M
Cash From Investing Activities -191.2K -263.1K -998.2K
Cash From Financing Activities -103.1K 21.90K 5.101M
Net Change In Cash -481.4K -1.737M -2.221M
YoY Change -120.39% -153.63% -210.74%
FREE CASH FLOW
Cash From Operating Activities -$155.0K -$1.496M -$6.340M
Capital Expenditures $191.2K $263.1K $30.84K
Free Cash Flow -$346.2K -$1.759M -$6.371M
YoY Change -69.89% 34.55% -5.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4732774
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3767472
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001718939
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.40
CY2022 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.20
CY2022 us-gaap Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#ImpairmentOfInvestments
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M6D
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41252
CY2022 dei Entity Registrant Name
EntityRegistrantName
T Stamp Inc
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3777260
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3017 Bolling Way NE, Floors 1 and 2
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30305
CY2022 dei City Area Code
CityAreaCode
404
CY2022 dei Local Phone Number
LocalPhoneNumber
806-9906
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
CY2022 dei Trading Symbol
TradingSymbol
IDAI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
24400000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4854332
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
Marlton, New Jersey
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254494
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3475695
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
109475
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
109194
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1008375
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1278286
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
31446
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
13648
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
580086
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2874401
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5764231
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1418672
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022Q4 us-gaap Goodwill
Goodwill
1248664
CY2021Q4 us-gaap Goodwill
Goodwill
1248664
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
251686
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
201807
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300664
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2066
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022Q4 us-gaap Assets
Assets
6411918
CY2021Q4 us-gaap Assets
Assets
8664654
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
945162
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
304140
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
273176
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
252773
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1099824
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1811680
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
503433
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21076
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177795
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
118860
CY2021Q4 idai Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
280108
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4447573
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2399986
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
261569
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
374694
CY2022Q4 idai Interest Payable Non Current
InterestPayableNonCurrent
16458
CY2021Q4 idai Interest Payable Non Current
InterestPayableNonCurrent
12252
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
886465
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
856258
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
88760
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
218239
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102407
CY2022Q4 us-gaap Liabilities
Liabilities
5786774
CY2021Q4 us-gaap Liabilities
Liabilities
3630938
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4910815
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4151542
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4854302
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4095029
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
48543
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
40950
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
56513
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
56513
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39496183
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31985880
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
18547
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
130267
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
237252
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
183900
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39299726
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27208186
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
463705
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4872277
CY2022Q4 us-gaap Minority Interest
MinorityInterest
161439
CY2021Q4 us-gaap Minority Interest
MinorityInterest
161439
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625144
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6411918
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8664654
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5385077
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3677896
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1785167
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1151057
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2474327
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2529501
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12444009
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8314575
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
760497
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
573755
CY2022 us-gaap Operating Expenses
OperatingExpenses
17464000
CY2021 us-gaap Operating Expenses
OperatingExpenses
12568888
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-12078923
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8890992
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8890
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-39970
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-113125
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
86944
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
27934
CY2021 idai Grant Income
GrantIncome
61601
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
50354
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
56932
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
118196
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
159533
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8459
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-167914
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12070464
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9058906
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21076
CY2022 us-gaap Profit Loss
ProfitLoss
-12091540
CY2021 us-gaap Profit Loss
ProfitLoss
-9058906
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1743
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12091540
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9057163
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.40
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.40
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4732774
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4732774
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3767472
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3767472
CY2022 us-gaap Profit Loss
ProfitLoss
-12091540
CY2021 us-gaap Profit Loss
ProfitLoss
-9058906
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
53352
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
138800
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53352
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
138800
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12038188
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8920106
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1743
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12038188
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8918363
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2073659
CY2021 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
150
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7633045
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1129535
CY2021 idai Repayment Of Shareholders Loan
RepaymentOfShareholdersLoan
75000
CY2021 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
261794
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2780639
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
138800
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1743
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9057163
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
3383762
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
95116
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1023645
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
667290
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-50980
CY2022 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
111720
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2399063
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
53352
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12091540
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625144
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12091540
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9057163
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1743
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
760497
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
573755
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2399063
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2780639
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-113125
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
86944
CY2022 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
111720
CY2021 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
261794
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
27934
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
16458
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
12252
CY2022 idai Non Cash Lease Expense
NonCashLeaseExpense
266086
CY2022 idai Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
281
CY2021 idai Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
109194
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-269911
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1137433
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
17798
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-857
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-373760
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
537607
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-178140
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-19816
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
630492
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-73565
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40290
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
250329
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
20403
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-195532
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1308247
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
34328
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
21076
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-258892
CY2022 idai Increase Decrease In Customer Deposits Liability
IncreaseDecreaseInCustomerDepositsLiability
-280108
CY2021 idai Increase Decrease In Customer Deposits Liability
IncreaseDecreaseInCustomerDepositsLiability
280108
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6337386
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6702221
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30842
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34217
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
776055
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
482219
CY2022 idai Payments For Proceeds From Intangible Assets
PaymentsForProceedsFromIntangibleAssets
-13362
CY2021 idai Payments For Proceeds From Intangible Assets
PaymentsForProceedsFromIntangibleAssets
90621
CY2022 idai Payments To Acquire Digital Assets
PaymentsToAcquireDigitalAssets
30000
CY2022 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
174655
CY2021 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
161296
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-998190
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-768353
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
983195
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7633045
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
667290
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1129535
CY2022 idai Proceeds From Exercise Of Warrants To Common Stock
ProceedsFromExerciseOfWarrantsToCommonStock
3383762
CY2021 idai Proceeds From Exercise Of Warrants To Common Stock
ProceedsFromExerciseOfWarrantsToCommonStock
150
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95116
CY2022 idai Proceeds From Loan From Maltese Government
ProceedsFromLoanFromMalteseGovernment
61361
CY2021 idai Proceeds From Loan From Maltese Government
ProceedsFromLoanFromMalteseGovernment
844006
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
344219
CY2021 idai Proceeds From Repayment Of Shareholder Loan
ProceedsFromRepaymentOfShareholderLoan
75000
CY2022 idai Principal Payment On Derivatives
PrincipalPaymentOnDerivatives
89530
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5101194
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9337517
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13181
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
138800
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2221201
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2005743
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3475695
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469952
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1254494
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3475695
CY2022 us-gaap Interest Paid Net
InterestPaidNet
8
CY2021 us-gaap Interest Paid Net
InterestPaidNet
30215
CY2022 idai Property And Equipment Financial Liability
PropertyAndEquipmentFinancialLiability
297150
CY2022 idai Operating Lease Right Of Use Assets Established Upon Adoption Of Asc842
OperatingLeaseRightOfUseAssetsEstablishedUponAdoptionOfAsc842
322559
CY2022 idai Operating Lease Liabilities Established Upon Adoption Of Asc842
OperatingLeaseLiabilitiesEstablishedUponAdoptionOfAsc842
302573
CY2022 idai Adjustment To Operating Lease Right Of Use Assets Related To Renewed Leases
AdjustmentToOperatingLeaseRightOfUseAssetsRelatedToRenewedLeases
259292
CY2022 idai Adjustment To Operating Lease Operating Lease Liabilities Related To Renewed Leases
AdjustmentToOperatingLeaseOperatingLeaseLiabilitiesRelatedToRenewedLeases
236521
CY2022 idai Prepaid Rent Expense Reclassified Upon Adoption Of Asc842
PrepaidRentExpenseReclassifiedUponAdoptionOfAsc842
42756
CY2021Q3 idai Amount Of Authorized Units
AmountOfAuthorizedUnits
5000000.00
CY2021Q3 idai Minimum Target Amount Under Offering
MinimumTargetAmountUnderOffering
100000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12090000.00
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6340000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates — </span>The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates that include, but are not limited to, percentage of completion related to revenue contracts that are not fully complete at the end of a fiscal quarter, capitalization and estimated useful life of internal-use software, the allowance for doubtful accounts, the fair value of financial assets and liabilities, the recoverability of goodwill, stock-based compensation including the determination of the fair value of our common stock, impairment of long-lived assets, the valuation of deferred tax assets and uncertain tax positions, and warrant liabilities. We base our estimates on assumptions, both historical and forward-looking trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Major Customers and Concentration of Risks</span><b style="font-weight:bold;"> —</b><i style="font-style:italic;"> </i>Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. We maintain our cash and cash equivalents with high-quality financial institutions mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of December 31, 2022 and 2021, the Company had $71 thousand and $2.25 million in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Three customers represented 96% or 37%, 33%, and 26% of the balance of total accounts receivable as of December 31, 2022 three customers represented 92% or 51%, 31%, and 10% of the balance of total accounts receivable as of December 31, 2021. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of December 31, 2022 and 2021, the Company had not experienced any significant losses on its accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2022, the Company sold to primarily three customers which made up approximately 93.60% of total Net revenue, and consisted of 61.01%, 18.36%, and 14.23% from ICE, an S&amp;P 500 Bank, and Mastercard, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Additionally, during the year ended December 31, 2021, the Company sold to primarily three customers which made up approximately 91.97% of total Net revenue, and consisted of 45.69%, 29.25%, and 17.03% from ICE, an S&amp;P 500 Bank, and Mastercard, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of, or substantial reduction, in statements of work from the Company’s major customers, could have a material effect on the consolidated financial statements. On August 17, 2022, Trust Stamp received notification from ICE that it was terminating the ICE Contract for convenience effective immediately.</p>
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
28000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
217000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
135000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
100425
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
71742
CY2021Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
68798
CY2021Q4 idai Prepaid Sponsorship Current
PrepaidSponsorshipCurrent
100000
CY2022Q4 idai Maximum Number Of Warrants Issued To Purchase Common Stock In Future
MaximumNumberOfWarrantsIssuedToPurchaseCommonStockInFuture
1000000.00
CY2022 idai Percentage Of Discount Of Future Issuance Of Preferred Stock
PercentageOfDiscountOfFutureIssuanceOfPreferredStock
0.20
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
50000
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6418
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1465083
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1550402
CY2021Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
67000
CY2020Q1 idai Warrants Strike Price
WarrantsStrikePrice
8.0000
CY2022Q3 idai Number Of Warrants Cancelled
NumberOfWarrantsCancelled
390000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.85
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
225756
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
319996
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
55981
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
75106
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
8368
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
332277
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
580086
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
CY2022 idai Capitalized Computer Software Useful Life
CapitalizedComputerSoftwareUsefulLife
P5Y
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3314450
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2538395
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1895778
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1378351
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1418672
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
517000
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
454000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
473202
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154009
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
172538
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42241
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300664
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022 us-gaap Depreciation
Depreciation
136000
CY2021 us-gaap Depreciation
Depreciation
50000
CY2022Q4 idai Digital Assets Noncurrent
DigitalAssetsNoncurrent
2066
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
178140
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2066
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.20
CY2022Q4 idai Compensation Payable
CompensationPayable
171851
CY2021Q4 idai Compensation Payable
CompensationPayable
597849
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
58771
CY2022Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
591992
CY2021Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
349256
CY2022Q4 idai Accrued Mobile Expenses Current
AccruedMobileExpensesCurrent
177099
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
100111
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
112427
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1099824
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450641
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
294629
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
198955
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
92822
CY2022Q4 idai Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
251686
CY2021Q4 idai Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
201807
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
140434
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
80940
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
30312
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251686
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5385077
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3677896
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7911970
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4808983
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4158494
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4249923
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12070464
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9058906
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5166
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
15910
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21076
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21076
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2534797
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1902004
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4081
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1560
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-494278
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-475504
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3146272
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2096141
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1083
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-99938
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
280890
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
21340
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7082125
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4975559
CY2022Q4 idai Deferred Tax Assets Amortization Of Research And Development Expenditures
DeferredTaxAssetsAmortizationOfResearchAndDevelopmentExpenditures
463749
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
335060
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
176975
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1660684
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1193450
CY2022Q4 idai Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
12292
CY2022Q4 idai Deferred Tax Assets Other Accruals
DeferredTaxAssetsOtherAccruals
4937
CY2021Q4 idai Deferred Tax Assets Other Accruals
DeferredTaxAssetsOtherAccruals
104807
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
14634
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
11528
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9573481
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6462319
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
198051
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
245453
CY2022Q4 idai Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
12082
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
210133
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
245453
CY2022Q4 idai Deferred Tax Assets Liabilities Net Total
DeferredTaxAssetsLiabilitiesNetTotal
9363348
CY2021Q4 idai Deferred Tax Assets Liabilities Net Total
DeferredTaxAssetsLiabilitiesNetTotal
6216866
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9363348
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6216866
CY2022 idai Net Increase Decrease In Valuation Allowance
NetIncreaseDecreaseInValuationAllowance
3146272
CY2021 idai Net Increase Decrease In Valuation Allowance
NetIncreaseDecreaseInValuationAllowance
2096141
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9363348
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6216866
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
83765
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
44244
CY2022Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12091540
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9057163
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4732774
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4732774
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3767472
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3767472
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.40
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.40
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
2420491
CY2021 us-gaap Dilutive Securities
DilutiveSecurities
2284674
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
346806
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.30
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M15D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
527450
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
52347
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.55
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4151
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.85
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
395002
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y5M1D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5365737
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7443
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15121
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.30
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
215
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.40
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
387109
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y5M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
387109
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.40
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y5M12D
CY2022Q4 idai Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue1
0
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.65
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.55
CY2022Q4 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
57000
CY2021Q4 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
500000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2399063
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2780639
CY2022Q4 idai Number Of Shares Authorized
NumberOfSharesAuthorized
52000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022 us-gaap Related Party Costs
RelatedPartyCosts
935000
CY2021 us-gaap Related Party Costs
RelatedPartyCosts
1080000.00
CY2022 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
138000
CY2021 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
32000
CY2021Q4 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2022Q4 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2020Q4 idai Loan Receivable Term
LoanReceivableTerm
P3Y
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
335000
CY2020Q4 idai Loans Receivable With Abated Interest Rate
LoansReceivableWithAbatedInterestRate
0.0025
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
281648
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.00
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P24M
CY2020Q4 idai Loans Receivable Kind In Services Per Month
LoansReceivableKindInServicesPerMonth
9000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P36M
CY2022Q4 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
19000
CY2021Q4 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
130000
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year One
PercentageOfCommissionReceivedOnNetSalesYearOne
0.20
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year Two
PercentageOfCommissionReceivedOnNetSalesYearTwo
0.10
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year Three
PercentageOfCommissionReceivedOnNetSalesYearThree
0.05
CY2020Q3 idai Maximum Amount Grant
MaximumAmountGrant
200000
CY2020Q3 idai Maximum Amount Grant
MaximumAmountGrant
251000
CY2020Q3 idai Requirement Of Initial Capital Amount
RequirementOfInitialCapitalAmount
50000
CY2020Q3 idai Requirement Of Initial Capital Amount
RequirementOfInitialCapitalAmount
62000
CY2020Q3 idai Reimbursement Of Grant For Initial Capital Amount
ReimbursementOfGrantForInitialCapitalAmount
50000
CY2020Q3 idai Reimbursement Of Grant For Initial Capital Amount
ReimbursementOfGrantForInitialCapitalAmount
62000
CY2020Q3 idai Remaining Reimbursement Amount Of Grant For Operating Expenses Incurred Up To12 Months From Incorporation
RemainingReimbursementAmountOfGrantForOperatingExpensesIncurredUpTo12MonthsFromIncorporation
150000
CY2020Q3 idai Remaining Reimbursement Amount Of Grant For Operating Expenses Incurred Up To12 Months From Incorporation
RemainingReimbursementAmountOfGrantForOperatingExpensesIncurredUpTo12MonthsFromIncorporation
190000
CY2021 idai Expenses Incurred For Grant
ExpensesIncurredForGrant
0
CY2022 idai Expenses Incurred For Grant
ExpensesIncurredForGrant
0
CY2022Q1 idai Percentage Of Aid Intensity To Cover Eligible Wage Cost
PercentageOfAidIntensityToCoverEligibleWageCost
0.75
CY2022Q4 idai Minimum Lease Commitments
MinimumLeaseCommitments
0
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
315765
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177795
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102407
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
280202
CY2022Q4 idai Lessee Operating Lease Liability Principal Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPrincipalPaymentsDueNextTwelveMonths
177795
CY2022Q4 idai Lessee Operating Lease Liability Imputed Interest Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityImputedInterestPaymentsDueNextTwelveMonths
7930
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
185725
CY2022Q4 idai Lessee Operating Lease Liability Principal Payments Due Year Two
LesseeOperatingLeaseLiabilityPrincipalPaymentsDueYearTwo
67882
CY2022Q4 idai Lessee Operating Lease Liability Imputed Interest Payments Due Year Two
LesseeOperatingLeaseLiabilityImputedInterestPaymentsDueYearTwo
3027
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
70909
CY2022Q4 idai Lessee Operating Lease Liability Principal Payments Due Year Three
LesseeOperatingLeaseLiabilityPrincipalPaymentsDueYearThree
33774
CY2022Q4 idai Lessee Operating Lease Liability Imputed Interest Payments Due Year Three
LesseeOperatingLeaseLiabilityImputedInterestPaymentsDueYearThree
551
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
34325
CY2022Q4 idai Lessee Operating Lease Liability Principal Payments Due Year Four
LesseeOperatingLeaseLiabilityPrincipalPaymentsDueYearFour
751
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
751
CY2022Q4 idai Lessee Operating Lease Liability Principal Payments Due
LesseeOperatingLeaseLiabilityPrincipalPaymentsDue
280202
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11508
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
291710
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
276562
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
90159
CY2022 us-gaap Lease Cost
LeaseCost
366721
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
258892
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
370493
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
76725
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
66427
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
59157
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4669
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
577471
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
208000
CY2022 idai Period From Time Each Mobile Hardware Asset Acquired
PeriodFromTimeEachMobileHardwareAssetAcquired
P30M
CY2022Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
118860
CY2022Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
88760
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
207620
CY2022 idai Period From Time Each Mobile Hardware Asset Acquired
PeriodFromTimeEachMobileHardwareAssetAcquired
P30M
CY2022 idai Period From Receipt And Activation Of Mobile Hardware
PeriodFromReceiptAndActivationOfMobileHardware
P30D
CY2022Q4 idai Financial Liability Current
FinancialLiabilityCurrent
119000
CY2022Q4 idai Financial Liability Noncurrent
FinancialLiabilityNoncurrent
89000

Files In Submission

Name View Source Status
idai-20221231_cal.xml Edgar Link unprocessable
idai-20221231_pre.xml Edgar Link unprocessable
0001410578-23-000453-index-headers.html Edgar Link pending
0001410578-23-000453-index.html Edgar Link pending
0001410578-23-000453.txt Edgar Link pending
0001410578-23-000453-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idai-20221231.xsd Edgar Link pending
idai-20221231x10k.htm Edgar Link pending
idai-20221231x10k001.jpg Edgar Link pending
idai-20221231x10k002.jpg Edgar Link pending
idai-20221231x10k003.jpg Edgar Link pending
idai-20221231x10k004.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
idai-20221231xex21d1.htm Edgar Link pending
idai-20221231xex23d1.htm Edgar Link pending
idai-20221231xex31d1.htm Edgar Link pending
idai-20221231xex31d2.htm Edgar Link pending
idai-20221231xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
idai-20221231_def.xml Edgar Link unprocessable
idai-20221231_lab.xml Edgar Link unprocessable
idai-20221231x10k_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending